Yuki Hirose

2.4k citations
123 papers · 1.3k indexed · h-index 18
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers)Pancreatic and Hepatic Oncology Research (19 papers)Gallbladder and Bile Duct Disorders (16 papers)
Partner nations
JapanUnited StatesIndia

In The Last Decade

Yuki Hirose

105 papers receiving 1.3k citations

Peers

Yuki Hirose
Comparison fields: 5 of 105
  • Molecular Biology 469
  • Oncology 372
  • Surgery 297
  • Pulmonary and Respiratory Medicine 240
  • Neurology 238
Replace Jiang Wu with:
Jiang Wu China
Ju‐Yeon Kim South Korea
Jing‐Ping Lin United States
Mineyoshi Aoyama Japan
Karolina A. Rygiel United Kingdom
Mary Kay Koenig United States
Pei‐Hsin Huang Taiwan
Gabriela D’Amico United Kingdom
Yi Wei China
Yuki Hirose relative to Jiang Wu China Jiang Wu's profile →
Citations per field
00.5×1.5×2.0×
Jiang Wu · 1×
Citations per year

Countries citing papers authored by Yuki Hirose

Since Specialization
Citations

This map shows the geographic impact of Yuki Hirose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Hirose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Hirose more than expected).

Fields of papers citing papers by Yuki Hirose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Hirose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Hirose. The network helps show where Yuki Hirose may publish in the future.

Co-authorship network of co-authors of Yuki Hirose

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Hirose. A scholar is included among the top collaborators of Yuki Hirose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Hirose. Yuki Hirose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 1
5 0
6 8
7 1
8 2
9 6
10 4
11 1
12 1
13 12
14 17
15 33
16 1
17 86
18 0
19 1
20 91

About Yuki Hirose

Yuki Hirose is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Oncology, having authored 123 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), Pancreatic and Hepatic Oncology Research (19 papers) and Gallbladder and Bile Duct Disorders (16 papers). The work is most often cited by research in Neurology (238 citations), Oncology (372 citations) and Cellular and Molecular Neuroscience (215 citations). Yuki Hirose has collaborated with scholars based in Japan, United States and India. Frequent co-authors include S Ohara, Toshifumi Wakai, N Ogawa, Ono T, Yasuo Watanabe, Masayuki Nagahashi, Takashi Kobayashi, Kazuaki Takabe, Kizuki Yuza and Kohei Miura. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026